Clinical Trial Update: Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's Disease [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate the efficacy and safety of HSK44459 in Behçet's disease. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease

Drugs mentioned

• HSK44459

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Behcet's Disease | Phase 2 | Status: NOT_YET_RECRUITING